Caring for Wounds: The Clinical Benefits of Extracorporeal Shock Wave Therapy
Management of chronic wounds is challenging across all care settings and also incurs high costs for both patients and health care systems. Extracorporeal shock wave therapy (ESWT) has the potential to decrease costs associated with treatment of diabetic foot ulcers, second-degree burns, and other complex wounds by shortening healing time.
This white paper on ESWT is sponsored by Tissue Regeneration Technologies (MTS Medical), the makers of SoftWave DermaGold 100. The guide describes the mechanism of action and classification of ESWT and the indications for use of this therapy, as well as providing an overview of diabetic foot ulcers, second-degree burns, and traumatic and surgical wounds.
This guide is a useful resource for wound care professionals who want to know more about ESWT, a non-invasive approach to optimal results in their patients with chronic wounds. It covers the following topics, among others:
This white paper contains information on the following topics:
This paper is written for wound care clinicians and purchasing directors with an interest in product solutions. This paper was developed by an independent third party.
Sponsored by SoftWave Tissue Regeneration Technologies.